SETTING: An urban area, The Gambia. OBJECTIVE: To identify ELISPOT and PPD skin test cut-offs, targeting sensitivity and specificity equivalence. DESIGN: Tuberculosis cases >5 years of age and their household contacts underwent ELISPOT, HIV and PPD skin tests. Cases and contacts sleeping in a different house were used to estimate sensitivity and specificity, providing two planes for estimating cut-offs. Specificity was adjusted for infection from previous exposure using a multivariate discrimination algorithm. RESULTS: The point on the line of intersection of the planes that maximised sensitivity and specificity equivalence occurred at 4 spots (95% confidence interval [CI] 3.5-5, multiplier=0 ) for CFP-10 and 5.5 spots (4.5-8, multiplier=0 for ESAT-6), yielding a sensitivity and specificity of 76% for both antigens. Combining ESAT-6 and CFP-10 using an 'or' statement yielded a maximum equivalence sensitivity and specificity of 76.5% at 6 spots for ESAT-6 and 11.5 spots for CFP-10. For the PPD skin test sensitivity and specificity, an equivalence of 78% occurred at 11 mm induration (9-13 mm). CONCLUSION: An ELISPOT cut-off for ESAT-6 or CFP-10 could be set at 4-8 spot forming units (20-40 spots per million), with little benefit from combining the results. A cut-off of 9-13 mm for the PPD skin test is reasonable when comparing with the ELISPOT.
SETTING: An urban area, The Gambia. OBJECTIVE: To identify ELISPOT and PPD skin test cut-offs, targeting sensitivity and specificity equivalence. DESIGN: Tuberculosis cases >5 years of age and their household contacts underwent ELISPOT, HIV and PPD skin tests. Cases and contacts sleeping in a different house were used to estimate sensitivity and specificity, providing two planes for estimating cut-offs. Specificity was adjusted for infection from previous exposure using a multivariate discrimination algorithm. RESULTS: The point on the line of intersection of the planes that maximised sensitivity and specificity equivalence occurred at 4 spots (95% confidence interval [CI] 3.5-5, multiplier=0 ) for CFP-10 and 5.5 spots (4.5-8, multiplier=0 for ESAT-6), yielding a sensitivity and specificity of 76% for both antigens. Combining ESAT-6 and CFP-10 using an 'or' statement yielded a maximum equivalence sensitivity and specificity of 76.5% at 6 spots for ESAT-6 and 11.5 spots for CFP-10. For the PPD skin test sensitivity and specificity, an equivalence of 78% occurred at 11 mm induration (9-13 mm). CONCLUSION: An ELISPOT cut-off for ESAT-6 or CFP-10 could be set at 4-8 spot forming units (20-40 spots per million), with little benefit from combining the results. A cut-off of 9-13 mm for the PPD skin test is reasonable when comparing with the ELISPOT.
Authors: Ifedayo M O Adetifa; Martin O C Ota; Brigitte Walther; Abdulrahman S Hammond; Moses D Lugos; David J Jeffries; Simon A Donkor; Richard A Adegbola; Philip C Hill Journal: PLoS One Date: 2010-09-01 Impact factor: 3.240
Authors: Philip C Hill; David J Jeffries; Roger H Brookes; Annette Fox; Dolly Jackson-Sillah; Moses D Lugos; Simon A Donkor; Bouke C de Jong; Tumani Corrah; Richard A Adegbola; Keith P McAdam Journal: PLoS One Date: 2007-01-31 Impact factor: 3.240
Authors: Sharon Perry; Bouke C de Jong; Jay V Solnick; Maria de la Luz Sanchez; Shufang Yang; Philana Ling Lin; Lori M Hansen; Najeeha Talat; Philip C Hill; Rabia Hussain; Richard A Adegbola; Joanne Flynn; Don Canfield; Julie Parsonnet Journal: PLoS One Date: 2010-01-20 Impact factor: 3.240
Authors: Bouke C de Jong; Abdulrahman Hammond; Jacob K Otu; Martin Antonio; Richard A Adegbola; Martin O Ota Journal: BMC Infect Dis Date: 2010-01-19 Impact factor: 3.090
Authors: Philip C Hill; Roger H Brookes; Annette Fox; Dolly Jackson-Sillah; David J Jeffries; Moses D Lugos; Simon A Donkor; Ifedayo M Adetifa; Bouke C de Jong; Alex M Aiken; Richard A Adegbola; Keith P McAdam Journal: PLoS Med Date: 2007-06 Impact factor: 11.069
Authors: Ifedayo M O Adetifa; Moses D Lugos; Abdulrahman Hammond; David Jeffries; Simon Donkor; Richard A Adegbola; Philip C Hill Journal: BMC Infect Dis Date: 2007-10-25 Impact factor: 3.090
Authors: Jedidah Mwacharo; Susanna J Dunachie; Oscar Kai; Adrian V S Hill; Philip Bejon; Helen A Fletcher Journal: PLoS One Date: 2009-12-23 Impact factor: 3.240